H.R. 2299 · 109th Congress
Generic Drugs Access Act of 2005
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
PalloneSponsorNo cosponsors.
Generic Drugs Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to include in an approval of an abbreviated application for a new drug a finding about whether the approved drug is the therapeutic equivalent of the previously approved or listed drug involved.
What it does: CRS summary · Introduced in House · May 11, 2005
Generic Drugs Access Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act to direct the Secretary of Health and Human Services to include in an approval of an abbreviated application for a new drug a finding about whether the approved drug is the therapeutic equivalent of the previously approved or listed drug involved. Sets forth criteria for a drug to be established as therapeutically equivalent.
Prohibits a state or its political subdivision from establishing or continuing any requirement that does not conform to the therapeutic equivalence requirement of this Act.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Generic Drugs Access Act of 2005
Latest action (May 23, 2005): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 11, 2005
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.